Fig. 2

Inducible expression pattern of DreI.

(A) ZFL cells seeded on 6-well plates overnight were transfected with 2 μg/ml poly I:C for 2, 6, 12, 48, 72, 96, and 120 h. Then total RNAs were extracted to examine the expression level of DreI transcripts by real-time PCR. β-actin was introduced as endogenous control. (B) Prokaryotic expression of the fusion protein DreI-His and generation of anti-DreI polyclonal antibody. Lane 1: lysate of normal bacteria; lane 2: lysate of IPTG-induced bacteria; lane 3: the purified protein by Ni²⁺-NTA affinity chromatography. (C) Transfection of ZFL cells with 2 μg/ml poly I:C for 48 h, the lysate was immunoblotted by polyclonal anti-DreI antiserum (lane 4), normal rabbit serum (lane 5) or anti-DreI antiserum pre-adsorbed with purified prokaryotic protein (lane 6). (D) ZFL cells were stimulated with 2 μg/ml poly I:C plus 4 μl/ml Lipofectamine 2000 for 12, 24, and 48 h, then lysed and detected by anti-DreI antiserum. β-actin served as an internal control. (E) For dose-dependent analysis, ZFL cells were treated with 1, 10, and 100 μg/ml poly I:C for 24 h. β-actin served as an internal control.